Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Madrigal Pharmaceuticals, Inc. Common Stock

MDGL Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of MDGL by members of U.S. Congress

MDGL Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
MDGL Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDGL Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in MDGL holdings by institutional investors

Quarterly net insider trading by MDGL's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $380,000 Jul 20, 2026 Issue: Medicare/Medicaid Health Issues
  • $380,000 Apr 24, 2026 Issue: Medicare/Medicaid Health Issues
  • $280,000 Jan 22, 2026 Issue: Medicare/Medicaid Health Issues
  • $30,000 Dec 04, 2025 Issue: Medicare/Medicaid
  • $60,000 Jul 16, 2025 Issue: Health Issues
  • $60,000 Apr 17, 2025 Issue: Health Issues
  • $60,000 Jan 19, 2025 Issue: Health Issues

Former government officials who have lobbied for MDGL

11 former government officials from 10 congressional offices at 4 lobbying firms have lobbied for MDGL, most recently Jul 15, 2026.

  • Pat Roberts
    Alison Anway Senate LA to Senator Pat Roberts 2006-2010 Formerly with Pat Roberts · BALLARD PARTNERS · Jul 15, 2026
  • Frank Pallone, Jr.
    Jeffrey Carroll House New Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone. Formerly with Frank Pallone, Jr. · CAPITOL COUNSEL LLC · Feb 18, 2026
  • Richard E. Neal
    Ann Jablon House New Chief of Staff, Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal. Formerly with Richard E. Neal · CAPITOL COUNSEL LLC · Feb 18, 2026
  • David Schweikert
    Charles Michaels House New Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint. Formerly with David Schweikert · CAPITOL COUNSEL LLC · Feb 18, 2026
  • George Sifakis Executive New Assistant to the President of the United States and Director of the Office of Public Liaison (President Trump, 2017). Formerly Assistant to the President of the United States and Director of the Office of Public Liaison (President Trump, 2017). · CAPITOL COUNSEL LLC · Feb 18, 2026
  • Tom Cotton
    John Martin Senate New Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton. Formerly with Tom Cotton · CAPITOL COUNSEL LLC · Feb 18, 2026
  • Joseph Crowley
    Eli Kogan House Sr. Legislative Assistant; Legislative Assistant; Legislative Aide; Legislative Correspondent - Representative Joe Crowley Formerly with Joseph Crowley · THORN RUN PARTNERS · Jan 19, 2026
  • Debbie Wasserman Schultz
    Tracie Pough House New Chief of Staff to U.S. Representative Debbie Wasserman Schultz 2003-2008 & 2009-2025 (Lobbying does not include House Appropriations) Formerly with Debbie Wasserman Schultz · BALLARD PARTNERS · Dec 09, 2025
See all 11 on the Revolving Door dashboard

MDGL Estimated quarterly lobbying spending

MDGL Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
MDGL Income Statement
MDGL Balance Sheet
MDGL Cash Flow
U.S. Patents

New MDGL patent grants

  • Patent Title: Methods for treating a fatty liver disease Jun. 30, 2026
  • Patent Title: Resmetirom for reducing liver volume Jun. 23, 2026
  • Patent Title: Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disorders Jun. 23, 2026
  • Patent Title: Methods for treating a fatty liver disease Aug. 05, 2025
  • Patent Title: Method of synthesizing thyroid hormone analogs and polymorphs thereof May. 21, 2024
  • Patent Title: Methods of treating liver disorders or lipid disorders with a thr-beta agonist Nov. 07, 2023
  • Patent Title: Methods of synthesizing thyroid hormone analogs and polymorphs thereof Jan. 31, 2023
  • Patent Title: Combination therapies comprising targeted therapeutics Nov. 08, 2022
  • Patent Title: Targeted therapeutics Jul. 05, 2022
  • Patent Title: Methods of treating liver disorders or lipid disorders with a thr-beta agonist Aug. 17, 2021
  • Patent Title: Methods of synthesizing thyroid hormone analogs and polymorphs thereof Jan. 19, 2021
  • Patent Title: Targeted therapeutics Nov. 10, 2020
  • Patent Title: Targeted therapeutics Jul. 28, 2020
  • Patent Title: Targeted therapeutics Jun. 09, 2020
  • Patent Title: Targeted therapeutics Aug. 13, 2019
  • Patent Title: Methods of synthesizing thyroid hormone analogs and polymorphs thereof Aug. 13, 2019
  • Patent Title: Targeted therapeutics Mar. 19, 2019
  • Patent Title: Targeted therapeutics Nov. 06, 2018
  • Patent Title: Method of synthesizing thyroid hormone analogs and polymorphs thereof May. 15, 2018
  • Patent Title: Targeted therapeutics May. 01, 2018
  • Patent Title: Compositions and methods for modulating c-rel-dependent cytokine production Mar. 06, 2018
  • Patent Title: Method of synthesizing thyroid hormone analogs and polymorphs thereof Feb. 23, 2016
  • Patent Title: Diacylglycerol acyltransferase inhibitors Dec. 04, 2012
  • Patent Title: Inhibitors of diacylglycerol acyltransferase Jul. 03, 2012
  • Patent Title: Diacylglycerol acyltransferase inhibitors Jul. 03, 2012
  • Patent Title: Diacylglycerol acyltransferase inhibitors Apr. 10, 2012
  • Patent Title: Inhibitors of diacylglycerol acyltransferase Feb. 28, 2012
  • Patent Title: Diacylglycerol acyltransferase inhibitors Feb. 14, 2012
Government Contracts

Estimated quarterly amount awarded to MDGL from public contracts

MDGL News

Recent insights relating to MDGL

CNBC Recommendations

Recent picks made for MDGL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDGL

MDGL Analyst Ratings

MDGL Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
MDGL Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $MDGL stock a Buy, Sell, or Hold?

  • What is the price target for $MDGL stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

MDGL Top Shareholders
Shareholder
Shares Held
MDGL Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $MDGL stock?

  • Who owns the most shares of $MDGL stock?

  • What funds own $MDGL stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDGL Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDGL Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About MDGL

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

  • Address West Conshohocken, PA
  • Market Cap 11.9 billion
  • Employees 915
  • Industrial Classification Pharmaceutical Preparations

Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Historical Stock Prices

Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) closed at $516.56 on September 25, 2026. Over the past year its adjusted close ranged from $412.35 to $602.83. Daily prices go back to January 2, 2014, 3,202 trading days in all.

  • 1 month-4.14%
  • 3 months+0.76%
  • Year to date-11.30%
  • 1 year+22.12%
  • 3 years+246.80%
  • 5 years+508.51%
  • Max+9,720.53%
See every congressional and insider trade on the MDGL price chart

Quiver Premium charts MDGL's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 513.75 523.96 511.31 516.56 516.56 153,394
Sep 24, 2026 513.65 521.77 510.57 513.21 513.21 219,343
Sep 23, 2026 523.00 526.00 502.62 513.02 513.02 315,951
Sep 22, 2026 525.77 528.42 516.62 518.83 518.83 266,074
Sep 21, 2026 536.04 536.04 515.98 521.96 521.96 186,148
Sep 18, 2026 535.08 537.73 526.65 531.52 531.52 330,617
Sep 17, 2026 534.69 539.29 526.25 534.40 534.40 153,313
Sep 16, 2026 523.00 529.93 517.45 529.09 529.09 298,474
Sep 15, 2026 539.25 539.71 513.36 523.26 523.26 259,412
Sep 14, 2026 540.00 541.35 527.97 540.06 540.06 156,535
Sep 11, 2026 536.02 546.56 531.37 534.49 534.49 187,643
Sep 10, 2026 543.12 543.12 519.10 533.12 533.12 225,766
Sep 9, 2026 529.50 549.97 526.88 546.66 546.66 281,255
Sep 8, 2026 534.17 540.00 526.67 534.16 534.16 199,463
Sep 4, 2026 536.82 547.92 535.60 541.08 541.08 177,171
Sep 3, 2026 548.83 552.08 540.44 542.61 542.61 143,455
Sep 2, 2026 543.54 551.45 537.10 546.93 546.93 202,818
Sep 1, 2026 540.03 548.60 532.65 538.71 538.71 165,754
Aug 31, 2026 530.60 542.05 523.29 540.03 540.03 134,578
Aug 28, 2026 539.38 542.16 528.28 533.76 533.76 268,664
Aug 27, 2026 538.46 545.82 532.30 543.69 543.69 221,853
Aug 26, 2026 510.14 550.33 507.48 538.88 538.88 345,540
Aug 25, 2026 515.95 523.35 506.29 512.16 512.16 189,200
Aug 24, 2026 515.89 517.00 507.18 511.97 511.97 145,523
Aug 21, 2026 520.09 530.67 514.90 516.74 516.74 179,832
Aug 20, 2026 537.01 539.73 518.65 519.09 519.09 264,483
Aug 19, 2026 528.99 542.77 527.46 540.16 540.16 221,134
Aug 18, 2026 524.50 533.68 514.57 524.37 524.37 356,197
Aug 17, 2026 509.16 527.22 506.85 524.87 524.87 307,441
Aug 14, 2026 504.34 509.89 494.90 507.56 507.56 234,655
Aug 13, 2026 539.73 540.00 506.02 507.37 507.37 277,891
Aug 12, 2026 536.00 544.49 527.59 536.20 536.20 285,551
Aug 11, 2026 516.97 535.57 512.79 535.27 535.27 415,197
Aug 10, 2026 502.92 517.48 501.21 515.34 515.34 283,738
Aug 7, 2026 511.97 517.32 502.79 510.04 510.04 347,529
Aug 6, 2026 513.28 524.45 509.00 510.36 510.36 296,763
Aug 5, 2026 510.88 517.00 503.64 514.12 514.12 349,534
Aug 4, 2026 492.73 513.76 489.23 507.56 507.56 442,367
Aug 3, 2026 462.15 485.95 461.25 482.00 482.00 463,916
Jul 31, 2026 490.00 490.23 460.11 467.32 467.32 795,264
Jul 30, 2026 505.55 510.55 447.01 493.11 493.11 1,487,716
Jul 29, 2026 541.59 550.89 536.00 546.88 546.88 356,878
Jul 28, 2026 551.50 561.15 532.96 538.80 538.80 218,771
Jul 27, 2026 555.00 566.18 548.68 551.25 551.25 268,615
Jul 24, 2026 544.37 547.91 537.00 544.51 544.51 147,390
Jul 23, 2026 537.65 549.04 526.61 543.35 543.35 160,514
Jul 22, 2026 546.78 552.73 536.42 537.65 537.65 310,899
Jul 21, 2026 534.50 548.53 534.50 546.79 546.79 222,279
Jul 20, 2026 555.00 555.05 533.00 535.69 535.69 223,809
Jul 17, 2026 538.85 560.09 536.01 553.48 553.48 528,309
Jul 16, 2026 549.62 553.55 532.64 545.53 545.53 238,337
Jul 15, 2026 536.05 555.70 529.63 550.25 550.25 264,309
Jul 14, 2026 526.26 539.45 522.70 536.86 536.86 241,715
Jul 13, 2026 534.05 539.15 526.14 531.00 531.00 287,887
Jul 10, 2026 564.94 564.94 529.50 536.70 536.70 294,015
Jul 9, 2026 564.87 569.44 548.36 560.01 560.01 379,035
Jul 8, 2026 542.43 566.68 540.87 565.40 565.40 468,252
Jul 7, 2026 534.96 554.00 529.80 545.36 545.36 318,420
Jul 6, 2026 523.68 537.24 522.06 529.48 529.48 230,982
Jul 2, 2026 512.34 529.73 507.60 528.10 528.10 221,894
Jul 1, 2026 539.67 542.97 512.74 514.39 514.39 303,751
Jun 30, 2026 526.32 545.87 520.60 536.95 536.95 393,459
Jun 29, 2026 520.34 531.99 506.00 527.28 527.28 446,960
Jun 26, 2026 517.66 532.33 505.63 512.65 512.65 2,500,271
Jun 25, 2026 507.06 520.86 505.05 513.79 513.79 362,445
Jun 24, 2026 516.83 527.71 509.06 509.76 509.76 399,805
Jun 23, 2026 513.36 522.00 507.57 513.43 513.43 266,383
Jun 22, 2026 513.23 517.54 500.80 512.88 512.88 281,844
Jun 18, 2026 500.38 511.28 485.56 505.75 505.75 486,993
Jun 17, 2026 499.65 509.04 493.05 499.86 499.86 273,215
Jun 16, 2026 505.34 507.75 493.00 501.19 501.19 319,890
Jun 15, 2026 479.98 500.71 474.52 499.76 499.76 284,647
Jun 12, 2026 474.28 486.10 469.07 480.77 480.77 207,461
Jun 11, 2026 467.50 478.78 460.89 474.28 474.28 278,769
Jun 10, 2026 477.93 485.55 471.32 471.32 471.32 287,530
Jun 9, 2026 474.52 480.50 470.83 476.89 476.89 285,812
Jun 8, 2026 486.80 490.00 465.00 467.28 467.28 262,728
Jun 5, 2026 494.49 495.18 481.62 486.98 486.98 187,088
Jun 4, 2026 495.32 497.83 486.17 492.83 492.83 219,096
Jun 3, 2026 450.61 490.12 445.20 488.15 488.15 264,459
Jun 2, 2026 475.80 476.96 451.74 452.86 452.86 427,211
Jun 1, 2026 495.74 496.07 479.00 481.23 481.23 234,030
May 29, 2026 514.57 520.30 496.62 497.27 497.27 436,007
May 28, 2026 523.96 529.86 513.07 515.96 515.96 236,999
May 27, 2026 524.30 535.76 521.16 527.67 527.67 144,103
May 26, 2026 516.48 529.00 508.01 524.28 524.28 330,935
May 22, 2026 513.00 520.89 507.06 517.26 517.26 160,813
May 21, 2026 510.96 519.99 503.26 513.59 513.59 210,723
May 20, 2026 518.72 523.15 499.34 513.47 513.47 361,114
May 19, 2026 520.00 528.99 508.86 511.82 511.82 258,878
May 18, 2026 522.19 523.85 501.02 522.23 522.23 325,810
May 15, 2026 540.56 543.78 522.40 523.69 523.69 222,473
May 14, 2026 522.34 547.24 518.32 539.89 539.89 343,567
May 13, 2026 510.44 523.57 506.02 518.87 518.87 374,901
May 12, 2026 494.06 511.11 490.13 510.26 510.26 235,034
May 11, 2026 511.32 513.36 493.57 497.03 497.03 307,741
May 8, 2026 535.00 541.57 510.00 510.04 510.04 379,309
May 7, 2026 534.10 542.00 512.28 534.86 534.86 384,498
May 6, 2026 531.20 559.00 519.88 539.73 539.73 569,273
May 5, 2026 518.22 522.01 497.23 502.47 502.47 331,161
May 4, 2026 510.50 524.80 509.66 518.66 518.66 183,825
May 1, 2026 518.11 520.77 504.00 513.72 513.72 196,655
Apr 30, 2026 518.58 523.85 511.00 517.39 517.39 227,357
Apr 29, 2026 512.60 519.05 501.59 518.58 518.58 153,842
Apr 28, 2026 523.98 528.28 515.08 516.69 516.69 218,438
Apr 27, 2026 510.88 524.31 508.51 520.09 520.09 216,076
Apr 24, 2026 518.00 522.18 500.97 512.39 512.39 205,749
Apr 23, 2026 529.14 535.29 516.49 518.74 518.74 330,189
Apr 22, 2026 531.69 536.32 523.24 529.14 529.14 199,179
Apr 21, 2026 526.49 534.39 516.43 527.69 527.69 209,266
Apr 20, 2026 530.66 530.66 521.92 527.11 527.11 297,094
Apr 17, 2026 529.94 536.86 522.81 532.02 532.02 345,698
Apr 16, 2026 515.11 526.87 510.58 524.76 524.76 198,216
Apr 15, 2026 529.81 529.81 510.70 518.58 518.58 226,354
Apr 14, 2026 532.10 539.16 518.80 524.99 524.99 302,738
Apr 13, 2026 524.28 534.52 523.26 525.67 525.67 363,796
Apr 10, 2026 525.00 526.50 507.54 519.61 519.61 294,637
Apr 9, 2026 516.96 525.99 510.64 524.30 524.30 268,890
Apr 8, 2026 514.83 521.00 503.93 519.75 519.75 345,605
Apr 7, 2026 527.96 530.59 504.70 511.89 511.89 347,710
Apr 6, 2026 538.36 547.18 530.41 533.88 533.88 293,933
Apr 2, 2026 531.19 547.98 522.49 546.89 546.89 345,032
Apr 1, 2026 531.32 545.25 525.00 529.84 529.84 423,056
Mar 31, 2026 514.64 538.80 510.40 523.47 523.47 505,872
Mar 30, 2026 511.00 522.00 502.14 505.34 505.34 372,701
Mar 27, 2026 515.70 523.34 498.03 510.68 510.68 487,193
Mar 26, 2026 457.29 572.20 455.56 518.76 518.76 1,373,753
Mar 25, 2026 448.79 471.72 448.49 461.93 461.93 303,515
Mar 24, 2026 445.00 449.13 437.05 445.04 445.04 234,716
Mar 23, 2026 447.96 454.98 442.40 447.72 447.72 222,397
Mar 20, 2026 454.81 466.90 438.87 441.16 441.16 574,111
Mar 19, 2026 442.64 460.00 439.68 454.22 454.22 281,945
Mar 18, 2026 440.00 446.18 427.76 442.00 442.00 315,014
Mar 17, 2026 440.02 452.20 440.02 443.18 443.18 194,155
Mar 16, 2026 446.84 455.00 440.00 440.83 440.83 360,238
Mar 13, 2026 440.64 448.07 434.30 444.83 444.83 220,755
Mar 12, 2026 427.27 441.37 421.55 438.73 438.73 288,029
Mar 11, 2026 427.95 438.00 426.04 431.53 431.53 281,270
Mar 10, 2026 433.04 443.42 430.21 432.78 432.78 254,464
Mar 9, 2026 429.42 438.84 418.72 433.20 433.20 288,858
Mar 6, 2026 431.65 439.43 421.88 432.83 432.83 476,025
Mar 5, 2026 434.50 444.43 426.96 439.34 439.34 275,373
Mar 4, 2026 429.86 443.61 423.98 434.80 434.80 265,111
Mar 3, 2026 428.69 433.56 416.21 425.85 425.85 287,865
Mar 2, 2026 430.23 438.73 421.45 435.62 435.62 217,954
Feb 27, 2026 441.33 442.50 430.01 432.00 432.00 407,556
Feb 26, 2026 437.20 448.13 430.00 445.85 445.85 338,001
Feb 25, 2026 440.00 447.00 434.67 435.01 435.01 474,570
Feb 24, 2026 437.92 452.30 431.14 440.00 440.00 311,874
Feb 23, 2026 424.20 440.99 424.20 437.79 437.79 540,192
Feb 20, 2026 435.01 448.15 424.49 435.01 435.01 468,970
Feb 19, 2026 452.02 461.98 427.78 436.87 436.87 1,228,060
Feb 18, 2026 486.71 498.10 480.00 491.49 491.49 316,817
Feb 17, 2026 462.37 495.00 462.04 487.32 487.32 403,068
Feb 13, 2026 474.31 482.99 458.07 464.71 464.71 245,800
Feb 12, 2026 483.90 484.25 468.08 473.79 473.79 256,434
Feb 11, 2026 483.03 483.03 463.53 481.00 481.00 298,176
Feb 10, 2026 488.30 499.55 475.34 478.83 478.83 432,160
Feb 9, 2026 477.60 490.50 471.39 488.26 488.26 397,913
Feb 6, 2026 475.69 482.88 465.20 477.60 477.60 338,615
Feb 5, 2026 478.90 486.88 458.00 463.42 463.42 382,883
Feb 4, 2026 478.75 482.06 472.52 478.61 478.61 350,267
Feb 3, 2026 486.17 491.29 467.86 482.45 482.45 339,931
Feb 2, 2026 483.11 497.73 481.02 489.73 489.73 256,922
Jan 30, 2026 489.75 497.54 480.02 489.31 489.31 668,552
Jan 29, 2026 497.38 500.14 485.96 494.69 494.69 264,611
Jan 28, 2026 504.36 506.39 492.00 496.54 496.54 180,944
Jan 27, 2026 495.03 501.68 487.88 500.39 500.39 244,436
Jan 26, 2026 476.71 502.36 474.86 499.17 499.17 336,527
Jan 23, 2026 497.32 499.00 465.98 480.45 480.45 434,832
Jan 22, 2026 496.97 504.00 492.01 498.04 498.04 231,520
Jan 21, 2026 498.30 505.00 492.69 496.97 496.97 313,300
Jan 20, 2026 491.94 506.61 483.55 504.95 504.95 222,773
Jan 16, 2026 495.75 511.94 492.50 501.68 501.68 276,248
Jan 15, 2026 503.65 510.50 495.36 495.88 495.88 217,630
Jan 14, 2026 492.60 508.76 487.19 505.23 505.23 346,659
Jan 13, 2026 511.57 514.36 493.19 493.90 493.90 430,391
Jan 12, 2026 513.87 517.71 504.49 510.53 510.53 297,359
Jan 9, 2026 554.99 555.10 511.03 514.06 514.06 703,253
Jan 8, 2026 559.91 568.00 547.80 556.22 556.22 264,487
Jan 7, 2026 560.87 589.98 558.29 561.13 561.13 402,084
Jan 6, 2026 575.02 578.50 532.45 558.01 558.01 732,348
Jan 5, 2026 592.21 592.99 572.52 588.40 588.40 341,503
Jan 2, 2026 582.02 598.79 580.00 593.87 593.87 281,989
Dec 31, 2025 583.21 592.72 581.52 582.34 582.34 155,807
Dec 30, 2025 588.39 590.00 578.00 583.73 583.73 139,211
Dec 29, 2025 598.00 599.98 587.02 589.47 589.47 293,651
Dec 26, 2025 608.34 608.34 597.70 598.91 598.91 97,809
Dec 24, 2025 601.36 615.00 601.36 602.82 602.82 103,015
Dec 23, 2025 597.61 609.80 593.00 602.21 602.21 214,052
Dec 22, 2025 585.21 609.98 585.21 602.83 602.83 329,486
Dec 19, 2025 552.42 593.59 551.38 591.02 591.02 967,681
Dec 18, 2025 546.00 555.50 535.33 544.41 544.41 348,438
Dec 17, 2025 551.90 561.00 544.85 546.19 546.19 239,776
Dec 16, 2025 554.78 560.00 544.24 554.57 554.57 270,722
Dec 15, 2025 571.84 573.67 552.75 560.55 560.55 245,801
Dec 12, 2025 570.11 577.21 561.05 571.44 571.44 177,491
Dec 11, 2025 559.13 589.67 554.00 571.33 571.33 292,477
Dec 10, 2025 552.97 555.39 546.20 552.47 552.47 315,988
Dec 9, 2025 565.80 569.83 550.70 553.92 553.92 287,945
Dec 8, 2025 576.90 576.97 561.20 568.57 568.57 333,215
Dec 5, 2025 585.39 593.00 573.00 577.30 577.30 220,906
Dec 4, 2025 582.59 594.27 573.00 586.21 586.21 219,569
Dec 3, 2025 579.67 592.88 570.50 579.89 579.89 264,717
Dec 2, 2025 579.90 598.77 569.04 573.15 573.15 290,938
Dec 1, 2025 593.82 594.03 577.59 579.45 579.45 298,162
Nov 28, 2025 600.00 605.00 590.34 596.98 596.98 116,258
Nov 26, 2025 592.04 604.81 585.09 601.03 601.03 254,376
Nov 25, 2025 588.27 594.46 566.99 592.04 592.04 359,795
Nov 24, 2025 547.96 594.99 545.00 587.92 587.92 762,692
Nov 21, 2025 542.85 565.15 535.00 547.96 547.96 567,226
Nov 20, 2025 562.71 571.16 540.01 542.12 542.12 270,698
Nov 19, 2025 554.39 570.24 553.24 555.60 555.60 237,464
Nov 18, 2025 545.38 577.90 545.38 558.99 558.99 353,058
Nov 17, 2025 525.00 555.12 520.45 553.42 553.42 471,000
Nov 14, 2025 509.50 534.95 505.00 529.21 529.21 263,414
Nov 13, 2025 527.37 531.00 513.82 514.93 514.93 296,051
Nov 12, 2025 536.39 542.19 520.00 528.94 528.94 452,769
Nov 11, 2025 491.39 544.25 491.39 541.50 541.50 508,376
Nov 10, 2025 498.00 505.05 486.04 495.88 495.88 324,312
Nov 7, 2025 488.03 494.55 476.61 489.26 489.26 294,188
Nov 6, 2025 471.22 491.91 471.22 488.58 488.58 397,829
Nov 5, 2025 450.90 496.98 446.20 475.87 475.87 778,259
Nov 4, 2025 406.22 469.95 405.00 444.64 444.64 1,249,060
Nov 3, 2025 421.64 430.50 399.00 412.35 412.35 623,324
Oct 31, 2025 428.50 433.12 410.50 418.90 418.90 385,618
Oct 30, 2025 423.74 434.98 420.50 427.52 427.52 288,407
Oct 29, 2025 427.07 434.48 393.61 421.60 421.60 668,131
Oct 28, 2025 430.14 435.00 426.65 429.18 429.18 279,302
Oct 27, 2025 423.61 436.84 423.61 435.78 435.78 261,762
Oct 24, 2025 426.63 429.98 417.35 421.50 421.50 163,786
Oct 23, 2025 415.96 424.92 415.00 423.87 423.87 232,494
Oct 22, 2025 426.57 430.25 413.82 415.95 415.95 287,981
Oct 21, 2025 435.86 445.06 427.06 430.00 430.00 249,800
Oct 20, 2025 442.97 442.97 418.56 439.97 439.97 278,980
Oct 17, 2025 434.95 440.17 427.52 438.90 438.90 202,060
Oct 16, 2025 433.45 449.02 433.45 442.13 442.13 272,416
Oct 15, 2025 444.33 451.41 425.02 433.45 433.45 262,987
Oct 14, 2025 426.56 439.45 420.02 437.10 437.10 241,692
Oct 13, 2025 427.07 430.75 420.00 427.73 427.73 280,778
Oct 10, 2025 428.71 445.00 416.29 429.60 429.60 419,302
Oct 9, 2025 433.96 443.60 425.60 428.30 428.30 299,459
Oct 8, 2025 444.09 444.09 435.21 436.95 436.95 178,474
Oct 7, 2025 441.12 444.14 433.00 436.28 436.28 240,958
Oct 6, 2025 446.25 449.33 435.70 442.31 442.31 257,877
Oct 3, 2025 446.23 453.58 442.74 443.01 443.01 219,954
Oct 2, 2025 447.93 462.88 446.63 449.64 449.64 261,049
Oct 1, 2025 450.65 463.62 448.99 449.14 449.14 267,217
Sep 30, 2025 442.41 460.22 438.98 458.66 458.66 465,910
Sep 29, 2025 427.85 448.69 417.70 443.10 443.10 327,876
Sep 26, 2025 425.70 428.25 419.41 424.23 424.23 375,924
Sep 25, 2025 424.82 429.12 421.06 422.99 422.99 185,663

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Madrigal Pharmaceuticals, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at MDGL, per a recent SEC DEF 14A filing. We estimate that the median employee at MADRIGAL PHARMACEUTICALS, INC. is paid $317,550.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation